- Home
- GERN vs APPS Comparison
GERN vs APPS Comparison
Compare GERN & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- APPS
- Stock Information
- Founded
- GERN 1990
- APPS N/A
- Country
- GERN United States
- APPS United States
- Employees
- GERN N/A
- APPS N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- APPS Multi-Sector Companies
- Sector
- GERN Health Care
- APPS Miscellaneous
- Exchange
- GERN Nasdaq
- APPS Nasdaq
- Market Cap
- GERN 700.6M
- APPS 562.7M
- IPO Year
- GERN 1996
- APPS N/A
- Fundamental
- Price
- GERN $1.17
- APPS $5.12
- Analyst Decision
- GERN Buy
- APPS Hold
- Analyst Count
- GERN 8
- APPS 3
- Target Price
- GERN $3.71
- APPS $3.33
- AVG Volume (30 Days)
- GERN 9.2M
- APPS 3.6M
- Earning Date
- GERN 08-06-2025
- APPS 08-05-2025
- Dividend Yield
- GERN N/A
- APPS N/A
- EPS Growth
- GERN N/A
- APPS N/A
- EPS
- GERN N/A
- APPS N/A
- Revenue
- GERN $116,293,000.00
- APPS $490,506,000.00
- Revenue This Year
- GERN $161.44
- APPS $8.47
- Revenue Next Year
- GERN $53.06
- APPS $8.74
- P/E Ratio
- GERN N/A
- APPS N/A
- Revenue Growth
- GERN 22264.04
- APPS N/A
- 52 Week Low
- GERN $1.09
- APPS $1.18
- 52 Week High
- GERN $4.89
- APPS $7.77
- Technical
- Relative Strength Index (RSI)
- GERN 39.34
- APPS 46.45
- Support Level
- GERN $1.20
- APPS $4.99
- Resistance Level
- GERN $1.37
- APPS $5.49
- Average True Range (ATR)
- GERN 0.08
- APPS 0.36
- MACD
- GERN -0.01
- APPS -0.04
- Stochastic Oscillator
- GERN 28.57
- APPS 24.49
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.